Survey Shows Companies Aim to Increase Range of Patient Data in Clinical Trials

Clinical Trials Advisor
Most life sciences companies plan to significantly step up their use of real-world data sources over the next three years, according to a new survey by the Tufts Center for the Study of Drug Development.

To View This Article:


Subscribe To Clinical Trials Advisor